Prospective European Drug-Induced Liver Injury Net
@EuropeanDILInet
objectives of the network are to co-ordinate efforts in DILI and to promote clinically impactful knowledge discovery and its translation into clinical practice.
See the new report from @BritPharmSoc & @RCPhysicians which calls for #pharmacogenomic testing, making #PersonalisedPrescribing a reality for patients, reducing side effects & the financial burden on the NHS: https://t.co/3qB9UWzUTZ prof Guru Aithal has contributed to this too!
Will you be @Eurotox2021? Make sure to attend @EuropeanDILInet seminar on Pre-clinical, Clinical and Regulatory Aspects of DILI Hazard Identification and Management with Paul Hayashi @US_FDA James Dear and Dominic Williams https://t.co/hDRLjAQYNg
In case you missed it - professors G. Aithal public lecture on DILI, precision medicine and more! Find it here: https://t.co/uDaCHvFCb2
We are very happy and proud to have prof. G. Aithal as our vice chair! <3
#dili#proeurodili#costaction#research
ECI Forum on July 15 with Ismael Alvarez and Hao Niu from Malaga University, IBIMA, who will be addressing talking about Clinical Trials and Drug-Induced Liver Injury: what have we learnt and where can we go. Click below to register! https://t.co/v7eu0QZgOF
We're launching a New Insights: Young Investigators Seminar Series! Join us on our first session with Nuria López Alcántara, who will share her experience and what she aims to develop in the future To register - click here: https://t.co/WueyHFwsXU
#dili#proeurodili#costaction
Members of the COST Action CA17112 are very happy to share their manuscript: "Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry". Enjoy your read here: https://t.co/ik1fnlcDhn #experience#dili#clinicalexcellence
Despite the pandemics, we @EuropeanDILInet are supporting young researchers! A Scientific mission in Malaga on #DILI non-clinical and clinical research has just started! Great collaboration between @Lithuania and University of Malaga! #COSTAction
@EuropeanDILInet looked into the current literature and we're happy to share our most recent systematic review and meta-analysis of randomised clinical trials on prevention and management of idiosyncratic drug-induced liver injury. Enjoy the read!
https://t.co/8Bs3jzMyYj
On 11/16 during the #digital@AASLDtweets meeting, @EuropeanDILInet Action prof Björnsson will discuss monitoring of liver tests, managing the effect of biologic drugs on the liver: ALF in patients on TNF-alpha inhibitors, checkpoint inhibitors, and other hot topics. Join him!
Make sure you take a look at the new CIOMS report "DILI: Current status and future directions for drug development and the post-market setting"
It was produced by leading experts from drug regulation, industry and research globally.
Find it here https://t.co/ItGoFYUGwi
Have you heard of Organ-on-Chip? Our WG3 co-leader dr. Leonard Nelson offers you an interesting read Organs-on-chips at the frontiers of drug discovery https://t.co/sJieA2XK46
Have any thoughts? Let's get in touch! https://t.co/M0l0gaQiwP
#drugdiscovery#preclincal#models
planning to attend @EASL Congress 2020 in London? Great! We will have a #COSTAction@EuropeanDILInet meeting on the 17th of April! For members of #ITC countries, we will be providing ITC Conference Grants to attend the meeting and give either an oral of poster presentation #DILI